ArticleInternational journal of breast cancer2026
Automated Segmentation and Analysis of Histopathological Breast Cancer Images for Enhanced IDC Diagnosis and Assessment Using MobileNetV2+U-Net With Label Propagation.
Article in International journal of breast cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Automated Segmentation and Analysis of Histopathological Breast Cancer Images for Enhanced IDC Diagnosis and Assessment Using MobileNetV2+U-Net With Label Propagation.International journal of breast cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer remains the most common cancer type among women, with invasive ductal carcinoma (IDC) responsible for almost 80% of cases. The exact histopathological segmentation of IDC is the premise of diagnosis, but manual observation of hematoxylin and eosin (H&E) stained slides is very time-consuming and results in interobserver variability. This work presents an automated IDC segmentation method with a lightweight hybrid deep learning framework by integrating U-Net with a MobileNetV2 encoder and a label propagation refinement module. This hybrid model leverages MobileNetV2's efficient depth-wise-separable convolutions for feature extraction, U-Net's encoder-decoder precision for boundary localization, and the label propagation step enhances spatial smoothness and anatomical consistency. Experiments are conducted on the BACH 2018 and BreakHis datasets at multiple magnification levels (40×, 100×, and 200×). The model reaches a precision of 94.85%, Dice coefficient of 94.63%, F1-score of 94.56%, and AUC of 94.65% on the BACH dataset and a precision of 93.87%, Dice of 94.24%, F1-score of 94.18%, and AUC of 93.93% on the BreakHis dataset. The proposed model surpasses several state-of-the-art techniques such as CNN and transformer-based models, including DeepLabV3, Mask R-CNN, Swin-UNet, and ViT-Histo. Cross-dataset validation yields a Dice of 92.10% and AUC of 93.70% from BACH → BreakHis, confirming robustness under domain shifts. Explainable AI analyses using Grad-CAM and SHAP confirmed accurate localization of diagnostically relevant regions. The proposed hybrid model of MobileNetV2 + U-Net with label propagation presents a computationally efficient and clinically reliable solution toward real-time, AI-assisted breast cancer histopathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.